The limits of free speech.
出版信息
Nature. 2012 Dec 20;492(7429):311. doi: 10.1038/492311a.
DOI:10.1038/492311a
PMID:23281497
Abstract
摘要
相似文献
1
The limits of free speech.
Nature. 2012 Dec 20;492(7429):311. doi: 10.1038/492311a.
2
Off-label or off-limits?
Nat Biotechnol. 2008 Aug;26(8):867-75. doi: 10.1038/nbt0808-867.
3
Off-label marketing and the First Amendment.
N Engl J Med. 2013 Jan 10;368(2):103-5. doi: 10.1056/NEJMp1214926. Epub 2012 Dec 12.
4
Free speech rights outweigh restrictions on promoting drugs off label, court rules.
BMJ. 2012 Dec 6;345:e8324. doi: 10.1136/bmj.e8324.
5
Off-label marketing: free speech or illegal promotion?
BMJ. 2013 Jan 22;346:f320. doi: 10.1136/bmj.f320.
6
FDA regulation of off-label drug promotion under attack.
JAMA. 2013 Feb 6;309(5):445-6. doi: 10.1001/jama.2012.207972.
7
Clinical trial transparency--antidote to weaker off-label-promotion rules?
N Engl J Med. 2014 Jul 3;371(1):1-3. doi: 10.1056/NEJMp1402969.
8
Company pays over $81m for allegedly promoting topiramate for unapproved uses.
BMJ. 2010 May 27;340:c2848. doi: 10.1136/bmj.c2848.
9
When true enough is not good enough.
Nat Med. 2013 Jan;19(1):1. doi: 10.1038/nm.3061.
10
Regulating Off-Label Promotion - A Critical Test.
N Engl J Med. 2016 Dec 15;375(24):2313-2315. doi: 10.1056/NEJMp1611755. Epub 2016 Nov 2.
Zotero 插件